top of page

Abnormal LFTs on Your Screen? A 3-Step Specialist Framework for Primary Care

Updated: Dec 31, 2025

female doctor looking at a tablet.
Doctor looking at results of a patient on a tablet.

Struggling with abnormal LFTs? Use Dr. Nimzing Ladep's 3-step specialist framework and the LiverCheck app to interpret lab results at the point of care.


Introduction: The 'Point-of-Care' Headache

You’re in a busy clinic. You open a lab report and see it: an isolated rise in ALT, a slightly "off" Bilirubin, or a persistent GGT elevation. The patient is sitting across from you, looking for answers.

Do you refer immediately? Do you wait and retest in 3 months? Or is this the early warning sign of something that requires an urgent workup?

In the $10 billion liver health industry, generic advice is everywhere. But in clinical practice, precision is the only thing that saves lives. ---


Step 1: Pattern Recognition Over Number Crunching

The biggest mistake in managing abnormal Liver Function Tests (LFTs) is treating the numbers as isolated figures. Hepatologists look for Patterns:


  • Hepatocellular Pattern: Predominant elevation in ALT/AST. Think viral hepatitis or fatty liver.

  • Cholestatic Pattern: Predominant elevation in ALP/GGT. Think bile duct issues or drug-induced injury.

  • Isolated Hyperbilirubinemia: Is it Gilbert’s syndrome, or are we missing hemolysis?

The Challenge: Memorizing every diagnostic algorithm is impossible in a 10-minute consultation.


Stop Searching, Start Solving: Don't spend your lunch break digging through outdated PDFs. I built LiverCheck to act as your digital specialist. Input the values, and get an instant, evidence-based differential diagnosis.
google badge icon

Step 2: Ruling Out the "Silent Killers"

Before you label a patient with "Mild NAFLD," you must rule out the high-stakes culprits.

  1. Alcohol & Meds: Are they on statins? Herbal supplements? (Remember my viral exposé on the detox scam).

  2. Viral Screen: Is a Hep B or Hep C screen indicated?

  3. The Metabolic Red Flag: If the patient has Type 2 Diabetes and abnormal LFTs, their risk of advanced fibrosis triples.

Step 3: Actionable Follow-up

A lab result is only as good as the management plan it triggers. Does this patient need an Ultrasound? A FibroScan? Or simple lifestyle modification?

For patients, the "Wait and See" approach often leads to "Google and Panic." For clinicians, it leads to referral bloat.


Why 27,000+ Users Trust Worthy Works Tools

Our app suite isn't built by a tech company; it's built by the Worthy Works Medical Team, led by Dr. Nimzing Ladep (MBBS, FRCP, PhD).

  • Evidence-Based: Aligned with WHO and international liver guidelines.

  • Point-of-Care: Designed to be used while the patient is in the room.

  • Trust: 4.8-star rating from clinicians worldwide.


Final Call to Action: Take the Specialist with You

The next time an abnormal LFT hits your screen, don't guess. Empower your clinical decision-making with the tool recognized by global health leaders.




 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page